Tichy, E., Torres Martí, A., Bassetti, M., Kongnakorn, T., Virgilio, R. D., Irani, P., & Charbonneau, C. (2020). Cost-effectiveness Comparison of Ceftazidime/Avibactam Versus Meropenem in the Empirical Treatment of Hospital-acquired Pneumonia, Including Ventilator-associated Pneumonia, in Italy.
Citación estilo ChicagoTichy, Eszter, Antoni Torres Martí, Matteo Bassetti, Thitima Kongnakorn, Roberto Di Virgilio, Paurus Irani, y Claudie Charbonneau. Cost-effectiveness Comparison of Ceftazidime/Avibactam Versus Meropenem in the Empirical Treatment of Hospital-acquired Pneumonia, Including Ventilator-associated Pneumonia, in Italy. 2020.
Cita MLATichy, Eszter, et al. Cost-effectiveness Comparison of Ceftazidime/Avibactam Versus Meropenem in the Empirical Treatment of Hospital-acquired Pneumonia, Including Ventilator-associated Pneumonia, in Italy. 2020.